SCHEMBL6663336

SCHEMBL6663336

CCOCn1cnc2c1c(=O)n(Cc1c(C)noc1C)c(=O)n2-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS2R8 Q9NYW2 11/20 0.41
ALDH1A1 P00352 4/20 0.39
TSHR P16473 4/20 0.39
RAB9A P51151 2/20 0.39
PLA2G1B P04054 1/20 0.39
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ATG4B Q9Y4P1 1/20 0.39
LMNA P02545 1/20 0.37
CRHBP P24387 1/20 0.37
HTT P42858 1/20 0.37
CRHR2 Q13324 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6665465 0.88 TAS2R8 (0.47) TAS2R8ALDH1A1TSHRRAB9APLA2G1B
SCHEMBL6664815 0.84 TAS2R8 (0.44) TAS2R8ALDH1A1TSHRRAB9APLA2G1B
SCHEMBL6665236 0.83 KMT2A (0.51) ALDH1A1TSHRMAPK1SMN1; SMN2LMNA
SCHEMBL6665174 0.80 KMT2A (0.46) ALDH1A1TSHRMAPK1SMN1; SMN2LMNA
SCHEMBL6659535 0.80 LMNA (0.47) ALDH1A1SMN1; SMN2LMNAHTTMEN1
SCHEMBL6661011 0.78 POLB (0.50) ALDH1A1SMN1; SMN2LMNAHTTMEN1
SCHEMBL6665787 0.78 SMN1; SMN2 (0.38) ALDH1A1TSHRMAPK1SMN1; SMN2LMNA
SCHEMBL6660040 0.76 KMT2A (0.44) ALDH1A1TSHRMAPK1SMN1; SMN2LMNA
SCHEMBL6666190 0.76 SMN1; SMN2 (0.41) ALDH1A1RAB9ASMN1; SMN2LMNAHTT
SCHEMBL6661746 0.76 KMT2A (0.44) ALDH1A1TSHRMAPK1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1257552-B1 XANTHINE DERIVATIVES, INTERMEDIATES AND USE FOR TREATING OSTEOPOROSIS AVENTIS PHARMA SA (FR) 2004-08-18 EP disclosed